By Professor Phillip David Stricker

Journal articles

Pidsley R; Lam D; Qu W; Peters TJ; Phuc-Loi L; Korbie D; Stirzaker C; Daly RJ; Stricker P; Kench JG; Horvath LG; Clark SJ, 2022, 'Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality', CLINICAL AND TRANSLATIONAL MEDICINE, 12, http://dx.doi.org/10.1002/ctm2.1030

de Barros HA; Remmers S; Luiting HB; van Leenders GJLH; Roobol MJ; Bekers EM; Amin A; Haynes AM; Delprado W; Stricker PD; van der Poel HG; van der Kwast TH; van Leeuwen PJ, 2022, 'Predictive Value of Cribriform and Intraductal Carcinoma for the Nomogram-based Selection of Prostate Cancer Patients for Pelvic Lymph Node Dissection', Urology, 168, pp. 156 - 164, http://dx.doi.org/10.1016/j.urology.2022.04.043

Jaratlerdsiri W; Jiang J; Gong T; Patrick SM; Willet C; Chew T; Lyons RJ; Haynes AM; Pasqualim G; Louw M; Kench JG; Campbell R; Horvath LG; Chan EKF; Wedge DC; Sadsad R; Brum IS; Mutambirwa SBA; Stricker PD; Bornman MSR; Hayes VM, 2022, 'African-specific molecular taxonomy of prostate cancer', Nature, 609, pp. 552 - 559, http://dx.doi.org/10.1038/s41586-022-05154-6

Doan P; Scheltema MJ; Amin A; Shnier R; Geboers B; Gondoputro W; Moses D; van Leeuwen PJ; Haynes AM; Matthews J; Brenner P; O'Neill G; Yuen C; Delprado W; Stricker P; Thompson J, 2022, 'Reply by Authors.', Investigative Urology, pp. 101097ju000000000000288502 - 101097ju000000000000288502, http://dx.doi.org/10.1097/ju.0000000000002885.02

Gondoputro W; Thompson J; Evans M; Bolton D; Frydenberg M; Murphy DG; Haynes AM; Agrawal S; Stricker P; Papa N, 2022, 'How Does Age Affect Urinary Continence following Robot-Assisted Radical Prostatectomy? A Prospective Multi-Institutional Study Using Independently Collected, Validated Questionnaires', Journal of Urology, 207, pp. 1048 - 1056, http://dx.doi.org/10.1097/JU.0000000000002391

Beckmann KR; Bangma CH; Helleman J; Bjartell A; Carroll PR; Morgan T; Nieboer D; Santaolalla A; Trock BJ; Valdagni R; Roobol MJ, 2022, 'Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the GAP3 global consortium database', PROSTATE, 82, pp. 876 - 879, http://dx.doi.org/10.1002/pros.24330

Olivier J; Li W; Nieboer D; Helleman J; Roobol M; Gnanapragasam V; Frydenberg M; Sugimoto M; Carroll P; Morgan TM; Valdagni R; Rubio-Briones J; Robert G; Stricker P; Hayen A; Schoots I; Haider M; Moore CM; Denton B; Villers A, 2022, 'Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium', European Urology Open Science, 35, pp. 59 - 67, http://dx.doi.org/10.1016/j.euros.2021.11.006

Gondoputro W; Scheltema MJ; Blazevski A; Doan P; Thompson JE; Amin A; Geboers B; Agrawal S; Siriwardana A; Van Leeuwen PJ; van Oosterom MN; Van Leeuwen FWB; Emmett L; Stricker PD, 2022, 'Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate Cancer', Journal of Nuclear Medicine, 63, pp. 1659 - 1664, http://dx.doi.org/10.2967/JNUMED.121.263743

Vis AN; van den Bergh RCN; van der Poel HG; Mottrie A; Stricker PD; Graefen M; Patel V; Rocco B; Lissenberg-Witte B; van Leeuwen PJ, 2022, 'Selection of patients for nerve sparing surgery in robot-assisted radical prostatectomy', BJUI Compass, 3, pp. 6 - 18, http://dx.doi.org/10.1002/bco2.115

Wu SZ; Roden DL; Al-Eryani G; Bartonicek N; Harvey K; Cazet AS; Chan CL; Junankar S; Hui MN; Millar EA; Beretov J; Horvath L; Joshua AM; Stricker P; Wilmott JS; Quek C; Long GV; Scolyer RA; Yeung BZ; Segara D; Mak C; Warrier S; Powell JE; O’Toole S; Lim E; Swarbrick A, 2021, 'Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysis', Genome Medicine, 13, http://dx.doi.org/10.1186/s13073-021-00885-z

Emmett L; Buteau J; Papa N; Moon D; Thompson J; Roberts MJ; Rasiah K; Pattison DA; Yaxley J; Thomas P; Hutton AC; Agrawal S; Amin A; Blazevski A; Chalasani V; Ho B; Nguyen A; Liu V; Lee J; Sheehan-Dare G; Kooner R; Coughlin G; Chan L; Cusick T; Namdarian B; Kapoor J; Alghazo O; Woo HH; Lawrentschuk N; Murphy D; Hofman MS; Stricker P, 2021, 'The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study[Formula presented]', European Urology, 80, pp. 682 - 689, http://dx.doi.org/10.1016/j.eururo.2021.08.002

Blazevski A; Gondoputro W; Scheltema MJ; Amin A; Geboers B; Barreto D; Haynes A-M; Shnier R; Delprado W; Agrawal S; Thompson JE; Stricker P, 2021, 'Salvage Robot-assisted Radical Prostatectomy Following Focal Ablation With Irreversible Electroporation: Feasibility, Oncological and Functional Outcomes', , http://dx.doi.org/10.21203/rs.3.rs-1027405/v1

Lin HM; Mak B; Yeung N; Huynh K; Meikle TG; Mellett NA; Kwan EM; Fettke H; Tran B; Davis ID; Mahon KL; Zhang A; Stockler MR; Briscoe K; Marx G; Crumbaker M; Stricker PD; Du P; Yu J; Jia S; Scheinberg T; Fitzpatrick M; Bonnitcha P; Sullivan DR; Joshua AM; Azad AA; Butler LM; Meikle PJ; Horvath LG, 2021, 'Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase', EBioMedicine, 72, http://dx.doi.org/10.1016/j.ebiom.2021.103625

Gondoputro W; Thompson J; Frydenberg M; Murphy DG; Bolton D; Stricker P; Papa N, 2021, 'Does age affect continence outcomes following robot-assisted radical prostatectomy? Results from an Australian multi-institutional study', EUROPEAN UROLOGY, 79, pp. S1626 - S1626, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000674144301424&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Blazevski A; Amin A; Scheltema MJ; Balakrishnan A; Haynes AM; Barreto D; Cusick T; Thompson J; Stricker PD, 2021, 'Focal ablation of apical prostate cancer lesions with irreversible electroporation (IRE)', World Journal of Urology, 39, pp. 1107 - 1114, http://dx.doi.org/10.1007/s00345-020-03275-z

Ende J; Amin A; Sheehan-Dare G; Cusick T; Ho B; Keane J; Nguyen A; Liu V; Lee J; Chan L; Chen A; Fullard K; Stricker P; Emmett L, 2021, 'Pilot Trial Comparing the Performance of 68Ga-PSMA-11 PET/CT to 18F-PSMA-1007 PET/ CT in the Detection of Prostate Cancer Recurrence in Men with Rising PSA Following Radical Prostatectomy', Journal of Radiology and Medical Imaging, https://meddocsonline.org/journal-of-radiology-and-medical-imaging/pilot-trial-comparing-the-performance-of-68Ga-PSMA-11-PET-CT-to-18F-PSMA-1007-PET-CT-in-the-detection-of-prostate-cancer-recurrence-in-men-with-rising-PSA-following-radical-prostatectomy.pdf

De Barros HA; Remmers S; Luiting HB; Van Leenders GJLH; Roobol MJ; Bekers EM; Amin A; Haynes AM; Delprado W; Stricker PD; Van Der Poel HG; Van Der Kwast TH; Van Leeuwen PJ, 2021, 'Cribriform and intraductal carcinoma do not improve the nomogram-based selection of prostate cancer patients for pelvic lymph node dissection', European Urology Open Science, 33, pp. S240 - S241, http://dx.doi.org/10.1016/s2666-1683(21)03107-4

Gondoputro W; Blazevski A; Amin A; Scheltema M; Agrawal S; Cusick T; Van Leeuwen P; Van Leeuwen F; Emmett L; Thompson J; Stricker P, 2021, 'MP50-05 INTERIM RESULTS FROM THE DETECT TRIAL: A PROSPECTIVE CLINICAL TRIAL EVALUATING ^99M TC-LABELLED PSMA RADIOGUIDED SURGERY TO AID THE INTRAOPERATIVE DETECTION OF LYMPH NODE METASTASES DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION FOR PROSTATE CANCER', Journal of Urology, 206, http://dx.doi.org/10.1097/ju.0000000000002076.05

Olivier J; Li W; Nieboer D; Helleman J; Gnanapragasam V; Frydenberg M; Kato T; Carroll P; Morgan TM; Valdagni R; Rubio-Briones J; Hyndman E; Robert G; Stricker P; Schoots I; Haider M; Moore C; Denton B; Villers A, 2021, 'PD17-03 PROSTATE CANCER PATIENTS THAT OPTED FOR ACTIVE SURVEILLANCE WHILE HAVING A SUSPICIOUS MRI ARE AT INCREASED RISK OF NEEDING TREATMENT. RESULTS OF THE MOVEMBER FOUNDATION’S GLOBAL ACTION PLAN PROSTATE CANCER ACTIVE SURVEILLANCE (GAP3) CONSORTIUM', Journal of Urology, 206, http://dx.doi.org/10.1097/ju.0000000000001999.03

Thompson J; Amin A; Stricker P, 2020, 'Magnetic Resonance Imaging Improves Selection for Active Surveillance and Can Extend the Interval Between Biopsies', European Urology, 78, pp. 518 - 519, http://dx.doi.org/10.1016/j.eururo.2020.07.001

Amin A; Scheltema MJ; Shnier R; Blazevski A; Moses D; Cusick T; Siriwardena A; Yuen B; Van Leeuwen PJ; Haynes AM; Matthews J; Brenner P; O'Neill G; Yuen C; Delprado W; Stricker P; Thompson J; Montorsi F; Gandaglia G; Fossati N; Briganti A, 2020, 'Re: The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies', Journal of Urology, 204, pp. 843, http://dx.doi.org/10.1097/JU.0000000000001190

, 2020, 'Reply by Authors', Journal of Urology, 204, pp. 843 - 844, http://dx.doi.org/10.1097/JU.0000000000001191

Thompson JE; Stricker PD, 2020, 'Editorial Comment', Journal of Urology, 204, pp. 495, http://dx.doi.org/10.1097/JU.0000000000000811.01

Algohary A; Shiradkar R; Pahwa S; Purysko A; Verma S; Moses D; Shnier R; Haynes AM; Delprado W; Thompson J; Tirumani S; Mahran A; Rastinehad AR; Ponsky L; Stricker PD; Madabhushi A, 2020, 'Combination of peri-tumoral and intra-tumoral radiomic features on bi-parametric mri accurately stratifies prostate cancer risk: A multi-site study', Cancers, 12, pp. 1 - 14, http://dx.doi.org/10.3390/cancers12082200

Wu S; Roden D; Al-Eryani G; Bartonicek N; Harvey K; Cazet A; Chan C-L; Junankar S; Hui M; Millar E; Beretov J; Horvath L; Joshua A; Stricker P; Wilmott J; Quek C; Long G; Scolyer R; Yeung B; Segara D; Mak C; Warrier S; Powell J; O'Toole S; Lim E; Swarbrick A, 2020, 'Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysis', bioRxiv, http://dx.doi.org/10.1101/2020.06.04.135277

Emmett L; Tang R; Nandurkar R; Hruby G; Roach P; Watts JA; Cusick T; Kneebone A; Ho B; Chan L; van Leeuwen PJ; Scheltema MJ; Nguyen A; Yin C; Scott A; Tang C; McCarthy M; Fullard K; Roberts M; Francis R; Stricker P, 2020, '3-year freedom from progression after ⁶⁸Ga-PSMA PET/CT-Triaged management in men with biochemical recurrence after radical prostatectomy: Results of a prospective multicenter trial', Journal of Nuclear Medicine, 61, pp. 866 - 872, http://dx.doi.org/10.2967/jnumed.119.235028

Miladinovic D; Cusick T; Mahon KL; Haynes AM; Cortie CH; Meyer BJ; Stricker PD; Wittert GA; Butler LM; Horvath LG; Hoy AJ, 2020, 'Assessment of periprostatic and subcutaneous adipose tissue lipolysis and adipocyte size from men with localized prostate cancer', Cancers, 12, http://dx.doi.org/10.3390/cancers12061385

Huits TH; Luiting HB; van der Poel HG; Nandurkar R; Donswijk M; Schaake E; Vogel W; Roobol MJ; Wit E; Stricker P; Emmett L; van Leeuwen PJ, 2020, 'Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen (⁶⁸Ga-PSMA) positron-emission/computed tomography after radical prostatectomy with pathological node-positive extended lymph node dissection', BJU International, 125, pp. 876 - 883, http://dx.doi.org/10.1111/bju.15052

Blazevski A; Scheltema MJ; Yuen B; Masand N; Nguyen TV; Delprado W; Shnier R; Haynes AM; Cusick T; Thompson J; Stricker P, 2020, 'Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort', European urology oncology, 3, pp. 283 - 290, http://dx.doi.org/10.1016/j.euo.2019.04.008

Crumbaker M; Chan EKF; Gong T; Corcoran N; Jaratlerdsiri W; Lyons RJ; Haynes AM; Kulidjian AA; Kalsbeek AMF; Petersen DC; Stricker PD; Jamieson CAM; Croucher PI; Hovens CM; Joshua AM; Hayes VM, 2020, 'The impact of whole genome data on therapeutic decision‐making in metastatic prostate cancer: A retrospective analysis', Cancers, 12, http://dx.doi.org/10.3390/cancers12051178

Amin A; Scheltema MJ; Shnier R; Blazevski A; Moses D; Cusick T; Siriwardena A; Yuen B; Van Leeuwen PJ; Haynes AM; Matthews J; Brenner P; O'Neill G; Yuen C; Delprado W; Stricker P; Thompson J, 2020, 'The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies', Journal of Urology, 203, pp. 910 - 917, http://dx.doi.org/10.1097/JU.0000000000000693

Amin A; Blazevski A; Thompson J; Scheltema MJ; Hofman MS; Murphy D; Lawrentschuk N; Sathianathen N; Kapoor J; Woo HH; Chalasani V; Rasiah K; van Leeuwen PJ; Tang R; Cusick T; Stricker P; Emmett L, 2020, 'Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer', BJU International, 125, pp. 515 - 524, http://dx.doi.org/10.1111/bju.14999

Blazevski A; Scheltema MJ; Amin A; Thompson JE; Lawrentschuk N; Stricker PD, 2020, 'Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment', BJU International, 125, pp. 369 - 378, http://dx.doi.org/10.1111/bju.14951

Luiting HB; van Leeuwen PJ; Busstra MB; Brabander T; van der Poel HG; Donswijk ML; Vis AN; Emmett L; Stricker PD; Roobol MJ, 2020, 'Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature', BJU International, 125, pp. 206 - 214, http://dx.doi.org/10.1111/bju.14944

Scheinberg T; Kench J; Stockler M; Mahon KL; Sebastian L; Stricker P; Joshua AM; Woo H; Thanigasalam R; Ahmadi N; Centenera MM; Butler LM; Horvath LG, 2020, 'Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: A study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer)', BMJ Open, 10, http://dx.doi.org/10.1136/bmjopen-2019-033667

Amin A; Blazevski A; Scheltema M; Stricker P, 2020, 'Transperineal biopsy of the prostate in a patient post abdominoperineal resection', Urology Case Reports, 28, http://dx.doi.org/10.1016/j.eucr.2019.101055

Lam TBL; MacLennan S; Willemse PPM; Mason MD; Plass K; Shepherd R; Baanders R; Bangma CH; Bjartell A; Bossi A; Briers E; Briganti A; Buddingh KT; Catto JWF; Colecchia M; Cox BW; Cumberbatch MG; Davies J; Davis NF; De Santis M; Dell'Oglio P; Deschamps A; Donaldson JF; Egawa S; Fankhauser CD; Fanti S; Fossati N; Gandaglia G; Gillessen S; Grivas N; Gross T; Grummet JP; Henry AM; Ingels A; Irani J; Lardas M; Liew M; Lin DW; Moris L; Omar MI; Pang KH; Paterson CC; Renard-Penna R; Ribal MJ; Roobol MJ; Rouprêt M; Rouvière O; Sancho Pardo G; Richenberg J; Schoots IG; Sedelaar JPM; Stricker P; Tilki D; Vahr Lauridsen S; van den Bergh RCN; Van den Broeck T; van der Kwast TH; van der Poel HG; van Leenders GJLH; Varma M; Violette PD; Wallis CJD; Wiegel T; Wilkinson K; Zattoni F; N'Dow JMO; Van Poppel H; Cornford P; Mottet N, 2019, 'EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)', European Urology, 76, pp. 790 - 813, http://dx.doi.org/10.1016/j.eururo.2019.09.020

Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L, 2019, 'Diagnostic accuracy of ⁶⁸Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of ⁶⁸Ga-PSMA PET to mpMRI', BJU International, 124, pp. 42 - 49, http://dx.doi.org/10.1111/bju.14794

Feng Y; Jaratlerdsiri W; Patrick SM; Lyons RJ; Haynes AM; Collins CC; Stricker PD; Bornman MSR; Hayes VM, 2019, 'Metagenomic analysis reveals a rich bacterial content in high-risk prostate tumors from African men', Prostate, 79, pp. 1731 - 1738, http://dx.doi.org/10.1002/pros.23897

Quinn DI; Stricker PD; Kench JG; Grogan J; Haynes AM; Henshall SM; Grygiel JJ; Delprado W; Turner JJ; Horvath LG; Mahon KL, 2019, 'p53 nuclear accumulation as an early indicator of lethal prostate cancer', British Journal of Cancer, 121, pp. 578 - 583, http://dx.doi.org/10.1038/s41416-019-0549-8

van Leeuwen PJ; Donswijk M; Nandurkar R; Stricker P; Ho B; Heijmink S; Wit EMK; Tillier C; van Muilenkom E; Nguyen Q; van der Poel HG; Emmett L, 2019, 'Gallium-68-prostate-specific membrane antigen (⁶⁸Ga-PSMA) positron emission tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate- and high-risk prostate cancer', BJU International, 124, pp. 62 - 68, http://dx.doi.org/10.1111/bju.14506

Scheltema MJ; Chang JI; van den Bos W; Böhm M; Delprado W; Gielchinsky I; de Reijke TM; de la Rosette JJ; Siriwardana AR; Shnier R; Stricker PD, 2019, 'Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible Electroporation', European Urology Focus, 5, pp. 585 - 591, http://dx.doi.org/10.1016/j.euf.2017.10.007

Stricker PD; Van Leeuwen PJ, 2019, 'Editorial Comment', Journal of Urology, 201, pp. 1142, http://dx.doi.org/10.1097/01.JU.0000554684.52942.bc

Zhang AY; Chiam K; Haupt Y; Fox S; Birch S; Tilley W; Butler LM; Knudsen K; Comstock C; Rasiah K; Grogan J; Mahon KL; Bianco-Miotto T; Ricciardelli C; Böhm M; Henshall S; Delprado W; Stricker P; Horvath LG; Kench JG, 2019, 'An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy', International Journal of Cancer, 144, pp. 1151 - 1159, http://dx.doi.org/10.1002/ijc.31906

Thompson JE; Stricker PD, 2019, 'Editorial Comment', Journal of Urology, 201, pp. 306 - 307, http://dx.doi.org/10.1097/01.JU.0000553007.26960.b9

Bancroft EK; Saya S; Page EC; Myhill K; Thomas S; Pope J; Chamberlain A; Hart R; Glover W; Cook J; Rosario DJ; Helfand BT; Selkirk CH; Davidson R; Longmuir M; Eccles DM; Gadea N; Brewer C; Barwell J; Salinas M; Greenhalgh L; Tischkowitz M; Henderson A; Evans DG; Buys SS; Eeles RA; Aaronson NK; Eeles R; Bancroft E; Page E; Kote-Jarai Z; Ardern-Jones A; Bangma C; Castro E; Dearnaley D; Falconer A; Foster C; Gronberg H; Hamdy FC; Johannsson OT; Khoo V; Eccles D; Lilja H; Evans G; Eyfjord J; Lubinski J; Maehle L; Mikropoulos C; Millner A; Mitra A; Offman J; Moynihan C; Rennert G; Suri M; Dias A; Taylor N; D'Mello L; Pope J; James P; Mitchell G; Shanley S; Richardson K; McKinley J; Petelin L; Murphy M; Mascarenhas L; Murphy D; Lam J; Taylor L; Miller C; Stapleton A; Chong M; Suthers G; Poplawski N; Tucker K; Andrews L; Duffy J; Millard R; Ward R; Williams R; Stricker P; Kirk J; Bowman M; Patel M; Harris M; O'Connell S; Hunt C; Smyth C; Frydenberg M; Lindeman G; Shackleton K; Morton C; Susman R; McGaughran J; Boon M; Pachter N; Townshend S; Schofield L; Nicholls C; Spigelman A; Gleeson M; Amor D; Burke J; Patterson B; Swindle P; Scott R; Foulkes W; Boshari T; Aprikian A; Jensen T; Bojeson A; Osther P; Skytte A-B; Cruger D; Tondering MK; Gerdes A-M; Schmutzler R; Rhiem K; Wihler P; Kast K; Griebsch C; Johannsson O; Stefansdottir V; Murthy V; Sarin R; Awatagiri K; Ghonge S; Kowtal P; Mulgund G; Gallagher D; Bambury R; Farrell M; Gallagher F; Kiernan I; Friedman E; Chen-Shtoyerman R; Basevitch A; Leibovici D; Melzer E; Ben-Yehoshua SJ; Nicolai N; Radice P; Valdagni R; Magnani T; Gay S; Teo SH; Tan HM; Yoon S-Y; Thong MK; Vasen H; Ringleberg J; van Asperen C; Kiemeney B; van Zelst-Stams W; Ausems MGEM; van der Luijt RB; van Os T; Ruijs MWG; Adank MA; Oldenburg RA; Helderman-van den Enden APTJM; Caanen BAH; Oosterwijk JC; Moller P; Brennhovd B; Medvik H; Hanslien E; Grindedal EM; Cybulski C; Wokolorczyk D; Teixeira M; Maia S; Peixoto A; Henrique R; Oliveira J; Goncalves N; Araujo L; Seixas M; Souto JP; Nogueira P; Copakova L; Zgajnar J; Krajc M; Vrecar A; Capella G; Ramon y Cajal T; Fisas D; Mora J; Esquena S; Balmana J; Morote J; Liljegren A; Hjalm-Eriksson M; Ekdahl K-J; Carlsson S; George A; Kemp Z; Wiggins J; Moss C; Van As N; Thompson A; Ogden C; Woodhouse C; Kumar P; Evans DG; Bulman B; Rothwell J; Tricker K; Wise G; Mercer C; McBride D; Costello P; Pearce A; Torokwa A; Paterson J; Clowes V; Taylor A; Newcombe B; Walker L; Halliday D; Stayner B; Fleming-Brown D; Snape K; Hanson H; Hodgson S; Brice G; Homfray T; Hammond C; Kohut K; Anjum U; Dearing A; Mencias M; Potter A; Renton C; Searle A; Hill K; Goodman S; Garcia L; Devlin G; Everest S; Nadolski M; Douglas F; Jobson I; Paez E; Donaldson A; Tomkins S; Langman C; Jacobs C; Pichert G; Shaw A; Kulkarni A; Tripathi V; Rose S; Compton C; Watson M; Reinholtz C; Brady A; Dorkins H; Melville A; Kosicka-Slawinska M; Cummings C; Kiesel V; Bartlett M; Randhawa K; Ellery N; Side L; Male A; Simon K; Rees K; Tidey L; Gurasashvili J; Nevitt L; Ingram S; Howell A; Rosario D; Catto J; Howson J; Ong K-R; Chapman C; Cole T; Heaton T; Hoffman J; Burgess L; Huber C; Islam F; Watt C; Duncan A; Kockelbergh R; Mzazi S; Dineen A; Sattar A; Kaemba B; Sidat Z; Patel N; Siguake K; Birt A; Poultney U; Umez-Eronini N; Mom J; Sutton V; Cornford P; Bermingham N; Yesildag P; Treherne K; Griffiths J; Cogley L; Gott H; Rubinstein WS; Hulick P; McGuire M; Shevrin D; Kaul K; Weissman S; Newlin A; Vogel K; Weiss S; Hook N; Buys S; Goldgar D; Conner T; Venne V; Stephenson R; Dechet C; Domchek S; Powers J; Rustgi N; Strom S; Arun B; Davis JW; Yamamura Y; Obeid E; Giri V; Gross L; Bealin L; Cooney K; Stoffel E; Okoth L, 2019, 'Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations', BJU INTERNATIONAL, 123, pp. 284 - 292, http://dx.doi.org/10.1111/bju.14412

Emmett L; Crumbaker M; Ho B; Willowson K; Eu P; Ratnayake L; Epstein R; Blanksby A; Horvath L; Guminski A; Mahon K; Gedye C; Yin C; Stricker P; Joshua AM, 2019, 'Results of a Prospective Phase 2 Pilot Trial of ¹⁷⁷ Lu–PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression', Clinical Genitourinary Cancer, 17, pp. 15 - 22, http://dx.doi.org/10.1016/j.clgc.2018.09.014

Nandurkar R; Van Leeuwen P; Stricker P; Woo H; Kooner R; Yuen C; O'Neill G; Ende D; Cusick T; Ho B; Hickey A; Emmett L, 2019, '68Ga-HBEDD PSMA-11 PET/CT staging prior to radical prostatectomy in prostate cancer patients: Diagnostic and predictive value for the biochemical response to surgery', British Journal of Radiology, 92, http://dx.doi.org/10.1259/bjr.20180667

van Leeuwen PJ; Emmett L; Donswijk ML; Stricker PD; Pos FJ; Wit E; van der Poel HG, 2019, 'Early outcomes after [⁶⁸Ga]PSMA-PET/CT guided salvage therapy in men with biochemical recurrence after radical prostatectomy', Tijdschrift voor Urologie, 9, pp. 2 - 8, http://dx.doi.org/10.1007/s13629-018-00215-w

Scheltema MJ; O’brien TJ; van den Bos W; de Bruin DM; Davalos RV; van den Geld CWM; Laguna MP; Neal RE; Varkarakis IM; Skolarikos A; Stricker PD; de Reijke TM; Arena CB; de la Rosette J, 2019, 'Numerical simulation modeling of the irreversible electroporation treatment zone for focal therapy of prostate cancer, correlation with whole-mount pathology and T2-weighted MRI sequences', Therapeutic Advances in Urology, 11, pp. 1 - 10, http://dx.doi.org/10.1177/1756287219852305

Back to profile page